EDITAS MEDICINE INC (EDIT)
US28106W1036 - Common Stock
ChartMill assigns a Buy % Consensus number of 74% to EDIT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.17. This target is 204.03% above the current price.
EDIT was analyzed by 24 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about EDIT.
In the previous month the buy percentage consensus was at a similar level.
EDIT was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-29 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-02-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-12-12 | Truist Securities | Maintains | Buy -> Buy |
| 2023-10-24 | Citigroup | Upgrade | Neutral -> Buy |
| 2023-10-18 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023-10-17 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-09-29 | Stifel | Upgrade | Hold -> Buy |
| 2023-09-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-29 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-08-03 | Oppenheimer | Reiterate | Perform -> Perform |
| 2023-06-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-13 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2023-05-09 | Oppenheimer | Reiterate | Perform |
| 2023-05-08 | Chardan Capital | Reiterate | Buy |
| 2023-05-08 | RBC Capital | Maintains | Sector Perform |
| 2023-05-08 | Credit Suisse | Maintains | Neutral |
| 2023-02-23 | Chardan Capital | Maintains | Buy |
| 2023-02-23 | RBC Capital | Maintains | Sector Perform |
| 2023-02-23 | Credit Suisse | Maintains | Neutral |
| 2023-02-01 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-01-24 | Morgan Stanley | Maintains | Underweight |
| 2023-01-23 | SVB Leerink | Maintains | Market Perform |
| 2023-01-10 | SVB Leerink | Maintains | Market Perform |
| 2023-01-04 | Wells Fargo | Maintains | Overweight |
| 2022-12-13 | Citigroup | Initiate | Neutral |
| 2022-11-18 | Chardan Capital | Maintains | Buy |
| 2022-11-18 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-11-18 | RBC Capital | Maintains | Sector Perform |